US Markets Advance as Peace Talk Hopes Ease Oil Pressure
Investment analysis for April 14, 2026: US equities gain on Iran peace talk hopes, energy exits pay off, and our 13 active positions reviewed in detail.
US Markets Advance as Peace Talk Hopes Ease Oil Pressure
Good Monday evening. If you read yesterday's Ceasefire Relief Meets Sticky Inflation: Week Ahead Investment Analysis, you know I walked into this week cautiously optimistic that the emerging peace talk narrative could give equities some breathing room. Day one delivered.
Here's the big picture in three sentences: diplomatic hopes around the US-Iran conflict lowered oil prices, which eased inflation fears, which reopened the door for growth stocks, small caps, a
Sign in to read the full article
Members get full access to all analysis, the complete track record, and weekly digests. Free during beta.
US Markets Advance as Peace Talk Hopes Ease Oil Pressure
Good Monday evening. If you read yesterday's Ceasefire Relief Meets Sticky Inflation: Week Ahead Investment Analysis, you know I walked into this week cautiously optimistic that the emerging peace talk narrative could give equities some breathing room. Day one delivered.
Here's the big picture in three sentences: diplomatic hopes around the US-Iran conflict lowered oil prices, which eased inflation fears, which reopened the door for growth stocks, small caps, and risk assets broadly. The S&P 500 rose 1.02% to 5,886, the Dow gained 0.63% to 48,218, the Nasdaq climbed 1.23%, and the Russell 2000 led with a 1.52% advance. The VIX slipped to 19.12. Not a rip-roaring rally, but a broad, healthy green session that rewarded risk-taking across most sectors. And one that makes more sense when you trace the cause-and-effect chain from geopolitics to sector rotation to regional markets.
Let me walk through what's driving all of this, and then we'll cover every position in the book.
The Iran Situation: Day 46 and a Glimmer of Diplomacy
We are now 46 days into the US-Iran conflict. That sentence still feels surreal to type. But the tone shifted today. As reported in today's headlines , "Oil prices ease on hopes of new US-Iran peace talks" and "Asia's stock markets surge, oil falls on hopes for US-Iran talks". Oil prices dropped on reports of new diplomatic channels between Washington and Tehran. This is the single most important data point of the session, and the cause-and-effect chain is straightforward:
Lower oil → cooler inflation narrative → lower bond yields → risk assets breathe.
Treasury yields confirmed the logic: the 10-year fell to 4.297% (down 0.46% on the day) and the 30-year eased to 4.90% (down 0.28%). When yields decline on easing geopolitical risk, it tells you the bond market is pricing in less inflation pressure. And that's exactly the environment where growth stocks and small caps outperform.
Now, I want to be careful here. "Hopes of peace talks" is not the same as "peace." We've seen this cycle before during this conflict: optimism builds, headlines hint at negotiations, markets rally, then talks stall and oil spikes again. BP reported what it called an "exceptional" quarter for its oil traders precisely because this volatility has been so persistent. As the headline put it: "BP Flags Exceptional Oil Trading Gain as Energy Prices Soar." Volatility is a trader's best friend and an investor's headache.
Two headlines worth watching closely. First, a sanctioned Chinese tanker passed through the Strait of Hormuz despite the US naval blockade. A direct challenge to enforcement that adds geopolitical complexity. Second, China dismissed its Vice Minister of Foreign Affairs Sun Weidong today, which could signal a shift in Beijing's diplomatic posture toward the region. Together, these stories remind us that the conflict's ripple effects extend well beyond Washington and Tehran.
The practical takeaway: energy volatility is far from over, but the direction of the headline risk shifted constructive today. That matters for positioning.
Why the Same Catalyst Moved Different Markets Differently
Before diving into positions, it's worth explaining why the same peace-talk catalyst produced such different outcomes across sectors and regions.
Small caps and tech led in the US because these are the most rate-sensitive parts of the market. When oil falls and inflation expectations ease, the implied path of interest rates gets friendlier. And that disproportionately benefits higher-growth, higher-duration assets. The S&P 500 Information Technology sector gained 1.72%, the Russell 2000 surged 1.52%, and financials rose as the yield curve maintained a healthy spread (more on that below).
Asia surged because Japan, South Korea, and Taiwan are major energy importers. Lower oil is a direct boost to their current accounts and corporate margins. Japan's Nikkei gained 2.43%, South Korea's KOSPI rose 2.74%, and Taiwan's Weighted Index climbed 2.37%. The headline "Asia's stock markets surge, oil falls on hopes for US-Iran talks" captured the dynamic perfectly.
Europe was the odd one out. The FTSE dipped 0.17%, the DAX fell 0.26%, the CAC 40 lost 0.29%, the Euro Stoxx 50 dropped 0.36%, and Spain's IBEX fell 0.99%. Why didn't Europe benefit from the same oil relief? Because the continent had its own headwind: LVMH missed estimates, as reported in today's headlines, which dragged down luxury names and consumer sentiment across the region. The CAC 40's underperformance relative to other European indices reflects Paris's heavy weighting toward luxury. Kering and Hermès are set to report soon, which will either confirm or push back against the "European luxury slowdown" narrative.
India was also notably weak, with the BSE Sensex falling 0.91% and the Nifty 50 down 0.86%. A reminder that not every emerging market trades on the same catalyst.
A Quick Note on How I Talk About Positions
For newer readers: when I reference a "confidence score," that's our internal measure of how strongly the evidence supports a trade's thesis at the time of entry, on a scale from 0 to 1.0. A "health review" score (out of 5) is a separate, ongoing assessment of whether the original thesis is still intact based on price action, fundamentals, and macro conditions. Think of confidence as the entry grade and health as the ongoing report card. I'll use both throughout the portfolio review below.
Why We Closed COP and XLE, and Why It Feels Right Today
Let's talk about the exits. Yesterday we closed our ConocoPhillips (COP) position at a 5.78% loss and our Energy Select Sector SPDR (XLE) at a 6.06% loss. Both had been flagged with deteriorating thesis reviews twice, and frankly, keeping them open any longer would have been throwing good money after bad.
Here's the honest postmortem: these were momentum trades entered during the initial geopolitical spike in oil prices. They were essentially the same bet, which doubled our exposure to a single thesis. COP and XLE are roughly 90% correlated. We learned the hard way that holding two positions with the same core driver is just one position with twice the risk.
The other lesson? Both were entered with confidence scores near coin-flip levels. Our track record now shows a 100% loss rate on positions opened below 0.60 confidence. That's a pattern I won't repeat. We've implemented a hard floor: nothing opens below 0.60 confidence going forward.
With oil easing on today's peace-talk hopes and energy stocks likely rangebound while diplomacy plays out, I feel good about the timing of these exits. Sometimes the best trade is the one you stop making.
Our Tech Positions: NVDA, MSFT, META, ADBE, TSM, and QQQ
Tech was the star of today's session. The S&P 500 Information Technology sector gained 1.72%, driven by the same chain: lower oil → lower yields → higher growth multiples. Our portfolio benefited directly.
Microsoft (MSFT) continues to be our strongest individual tech performer, now up 2.92% from entry. With strong margins and a dominant position in enterprise AI, this remains one of the highest-conviction names in the book. The thesis is intact, the health review is clean at 5/5, and days like today are exactly why we added it.
NVIDIA (NVDA) is essentially flat from entry, up 0.36%. At a company growing revenue at 73%, I remain patient. The AI capital expenditure cycle hasn't slowed, and NVDA is the toll booth on that highway. Thesis intact.
Meta Platforms (META) is now up 0.74% from entry. Strong revenue growth and healthy margins at a reasonable forward multiple still look like a mispricing to me. Today's broad tech strength carried it higher, and the 5/5 health score reflects a thesis that's working.
Taiwan Semiconductor (TSM) is our second-best performer, up 10.45% from entry. Taiwan's Weighted Index rose 2.37% today, boosted by the same peace-talk-driven risk appetite that lifted all of Asia. TSM benefits from the AI chip demand thesis alongside NVDA, just from the manufacturing side. Worth noting that geopolitical sensitivity around Taiwan remains a background risk, but the fundamentals continue to speak loudly.
Adobe (ADBE) is our one tech position that's still underwater, down 1.03% from entry. I'll be honest: this one has the lowest confidence score among our tech names at 0.58, which is below the new 0.60 hard floor we've since implemented. Since ADBE was opened before that rule was established, it's grandfathered in. But it's on a shorter leash. The review system has it at 5/5 health, meaning the thesis hasn't broken, but the AI transformation story needs to start showing up in the numbers. I'm watching, not panicking.
Our QQQ position, which provides broad Nasdaq 100 exposure, is up 1.03% from entry (QQQ closed at $617.39 today). As I discussed in yesterday's post, we added this specifically because our track record analysis showed we needed more core beta. It's doing exactly what it was designed to do.
Defensive Holdings: AMGN, PEP, MRK
An interesting divergence today. While growth names rallied, defensive sectors lagged. The classic "risk-on" rotation where money flows out of safety and into growth.
PepsiCo (PEP) slipped from our entry. Not concerned. We bought PEP for its yield and portfolio stability, not as a momentum trade. Staples tend to lag on days when everything else rallies. That's the feature, not the bug. Thesis intact at 5/5.
Amgen (AMGN) is off 0.34% from entry. Same story as PEP: this is our healthcare compounder with a defensive profile. It won't lead on big green days, but it won't crater on red ones either. Holding with conviction.
Merck (MRK) is down 0.60% from entry with a 2.8% yield and strong margins. At a reasonable valuation, this is exactly the kind of name I want when the peace talk optimism fades and markets get nervous again. Because they will.
SPY and BAC: Our Beta and Financials Plays
SPY is our best-performing position by delta, up 4.62% from entry (SPY closed at $686.10 today, up 0.98%). This is the clearest proof that our strategic pivot is working. When we trailed the S&P 500 by over 4 percentage points, we added SPY directly. Simple, boring, effective. Sometimes the smartest investment analysis leads you right back to the index.
Bank of America (BAC) is up 8.04%, our second-best performer. Financials benefited from the steepening yield curve: the 10-year sits at 4.297% while the 3-month yield is at 3.603%, giving us a spread of roughly 69 basis points. When long-term rates exceed short-term rates by a healthy margin, banks make more money on the spread between what they pay depositors and what they earn on loans. That's the thesis in one sentence, and it's working.
ETH and BABA: Our Higher-Risk Names
Ethereum (ETH-USD) is up 14.63% from entry, our biggest winner in percentage terms. Crypto has been riding a strong momentum wave, and ETH in particular has benefited from the broader recovery in risk assets. At 0.58 confidence, this was always a higher-risk, higher-reward position opened before our new hard floor was in place. So far, the reward side is showing up.
Alibaba (BABA) is up 1.86% from entry, but this remains our most concerning position. Confidence was just 0.28 at entry. Well below our current standards. And our review system flagged minor concerns at 4/5 health. Like ADBE and ETH, this position predates the 0.60 confidence floor and is grandfathered in, but under active monitoring. The dismissal of China's Vice Minister of Foreign Affairs today adds another layer of uncertainty to the US-China relationship. I won't sugarcoat it: this position has a weakened thesis. If conditions deteriorate further, our automated review will act.
What I'm Watching Next
The big question for the rest of the week is whether these Iran peace talks produce anything tangible. If they do, oil should continue easing, which supports the broad equity rally and benefits energy-importing economies across Asia. If they don't, expect another spike in volatility. And probably a rotation back into the defensive names that lagged today.
I'm also watching the yield curve closely. The 10-year at 4.297% and the 30-year at 4.90% suggest the bond market isn't fully buying the disinflation story yet. If yields push higher from here, it could cap how far equities can run, especially in rate-sensitive growth names.
On the European front, Kering and Hermès earnings this week will tell us whether LVMH's miss was company-specific or the beginning of a broader luxury spending downturn. That distinction matters for global consumer sentiment.
What would change my mind? If peace talks collapse and oil spikes back to recent highs, I'd expect a sharp reversal in everything that worked today. Tech, small caps, and Asian markets. In that scenario, our defensive names (PEP, AMGN, MRK) would earn their keep, and I'd be looking to add more hedges. Conversely, if talks advance materially, we'd likely trim defensives and add to growth.
For our portfolio specifically, the story is one of improving discipline. We cut our losses on energy, added core beta through SPY and QQQ, and our high-conviction positions in MSFT, BAC, and TSM are pulling their weight. The gap to the benchmark is narrowing. Not fast enough for my liking, but heading in the right direction.
One thing I know for sure after four weeks of running this book: the market doesn't care about your thesis if your thesis is wrong. Cut fast, size according to conviction, and never hold two positions that are secretly the same bet. Those three rules would have saved us a lot of pain.
This content is for educational and informational purposes only. It does not constitute financial advice. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.
This content is for educational and informational purposes only. It does not constitute financial advice. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.